Hospital Clínica Bíblica is a hospital in San José, Costa Rica. The Clínica Bíblica Hospital is the largest private hospital of Costa Rica, founded in 1929.

During the past decade, Hospital Clínica Bíblica conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Clínica Bíblica" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored, "Human Genome Sciences Inc." with 1 trials sponsored, "Instituto de Atención Pediátrica" with 1 trials sponsored and "Karla Andrea Arias Varela" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clínica Bíblica" #1 collaborator was "Ben-Gurion University of the Negev" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Clínica Bíblica" are "Alzheimer's Disease" (1 trials), "Arthritis, Rheumatoid" (1 trials), "Complex Partial Seizure Disorder" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Epilepsies, Partial" (1 trials). Many other conditions were trialed in "Hospital Clínica Bíblica" in a lesser frequency.

Most popular intervention types in "Hospital Clínica Bíblica" are "Drug" (8 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Belimumab 1 mg/kg" (1 trials), "Belimumab 10 mg/kg" (1 trials), "Blood culture" (1 trials) and "Crenezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Clínica Bíblica" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Clínica Bíblica". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hospital Clínica Bíblica, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Clínica Bíblica, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".